Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Beneficial health effects of modest weight loss.

Goldstein DJ.

Int J Obes Relat Metab Disord. 1992 Jun;16(6):397-415. Review.

PMID:
1322866
2.

Updated review on the benefits of weight loss.

Vidal J.

Int J Obes Relat Metab Disord. 2002 Dec;26 Suppl 4:S25-8. Review.

PMID:
12457296
3.

Benefits and limitations of very-low-calorie diet therapy in obese NIDDM.

Henry RR, Gumbiner B.

Diabetes Care. 1991 Sep;14(9):802-23. Review.

PMID:
1959474
4.

Benefits of sustained moderate weight loss in obesity.

Pasanisi F, Contaldo F, de Simone G, Mancini M.

Nutr Metab Cardiovasc Dis. 2001 Dec;11(6):401-6. Review.

PMID:
12055705
5.

What are the benefits of moderate weight loss?

de Leiva A.

Exp Clin Endocrinol Diabetes. 1998;106 Suppl 2:10-3. Review.

PMID:
9792475
6.

Insulin resistance: the link between obesity and cardiovascular disease.

Reaven GM.

Med Clin North Am. 2011 Sep;95(5):875-92. doi: 10.1016/j.mcna.2011.06.002. Review.

PMID:
21855697
7.

Exercise training in obese diabetic patients. Special considerations.

Zierath JR, Wallberg-Henriksson H.

Sports Med. 1992 Sep;14(3):171-89. Review.

PMID:
1439393
8.

Outcome success in obesity.

Klein S.

Obes Res. 2001 Nov;9 Suppl 4:354S-358S. Review.

9.

Treatment of metabolic syndrome.

Wagh A, Stone NJ.

Expert Rev Cardiovasc Ther. 2004 Mar;2(2):213-28. Review.

PMID:
15151470
10.

Long-term effects of bariatric surgery on type II diabetes, hypertension and hyperlipidemia: a meta-analysis and meta-regression study with 5-year follow-up.

Ricci C, Gaeta M, Rausa E, Asti E, Bandera F, Bonavina L.

Obes Surg. 2015 Mar;25(3):397-405. doi: 10.1007/s11695-014-1442-4. Review.

PMID:
25240392
11.

Overweight, obesity, and blood pressure: the effects of modest weight reduction.

Mertens IL, Van Gaal LF.

Obes Res. 2000 May;8(3):270-8. Review.

12.

Cardiovascular implications of antihyperglycemic therapies for type 2 diabetes.

Ovalle F.

Clin Ther. 2011 Apr;33(4):393-407. doi: 10.1016/j.clinthera.2011.04.006. Review.

PMID:
21635987
13.
15.

Treatment of the obese patient in primary care: targeting and meeting goals and expectations.

Bray G, Look M, Ryan D.

Postgrad Med. 2013 Sep;125(5):67-77. doi: 10.3810/pgm.2013.09.2692. Review.

PMID:
24113665
16.

Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement.

Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM.

Health Technol Assess. 2004 May;8(21):iii-iv, 1-182. Review.

17.

Advances in medical therapy for weight loss and the weight-centric management of type 2 diabetes mellitus.

Igel LI, Powell AG, Apovian CM, Aronne LJ.

Curr Atheroscler Rep. 2012 Feb;14(1):60-9. doi: 10.1007/s11883-011-0221-0. Review.

PMID:
22113707
18.

[The treatment of obesity-related hypertension].

Skoczylas A.

Wiad Lek. 2006;59(5-6):403-6. Review. Polish.

PMID:
17017491
19.

Nutritional management of type 2 diabetes mellitus and obesity and pharmacologic therapies to facilitate weight loss.

Vetter ML, Amaro A, Volger S.

Postgrad Med. 2014 Jan;126(1):139-52. doi: 10.3810/pgm.2014.01.2734. Review.

PMID:
24393761
20.

Diet and pharmacologic therapy of obesity to modify atherosclerosis.

Jones PH.

Curr Atheroscler Rep. 2000 Jul;2(4):314-20. Review.

PMID:
11122760

Supplemental Content

Support Center